Of note, as opposed to hereditary thrombocytosis caused by MPL gain-of-function mutations, CAMT constitutes the clinical correlate to germline MPL loss-of-function mutations [60, 61], and association with aplastic anemia has been described in this context [62]. The gene discussed is MPL; the disease is aplastic anemia.